From Concept to Clinical Product: A Brief History of the Novel <i>Shigella</i> Invaplex Vaccine's Refinement and Evolution.

Vaccines (Basel) · 2022 · PMC9025769 · PMID 35455297

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

The level of protection was highly significant against both challenge organisms.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.